Thematic ETFs create the potential for outsized growthin your portfolio.
Missing out on higher growth?
Thematic ETFs create the potential for outsized growth in your portfolio.
ETF Securities provides a range of investment solutions to help you achieve better investment outcomes. This year we are seeing significant opportunities around our thematic funds that provide exposure to the battery technology supply chain and biotechnology in healthcare.
ETFS Battery Tech & Lithium ETF (ASX Code: ACDC) Battery storage will need to expand 300x its existing capacity to meet demand in 2050.1
Exposure to the lithium mining and electrochemical energy storage supply chain. Equal weighted portfolio that includes Pilbara Minerals, Tesla, and LG Chem.
ETFS S&P Biotech ETF (ASX Code: CURE) The US Biotech subsector has grown from a market capitalisation of US$212 billion in June 2009 to US$1.2 trillion in December 2020.2
Provides exposure to US listed stocks in the biotechnology sub-sector of healthcare.Equal weighted portfolio that includes Moderna, Amgen, Gilead Sciences and Novavax.
Contact us to find out more about ACDC and CURE. Client Services Line: +61 (2) 8311 3488 infoAU@etfsecurities.com.au www.etfsecurities.com.au To invest, search for ASX Code: ACDC and ASX Code: CUREthrough your trading platform.
[1]https://www.irena.org/publications/2020/Apr/Global-Renewables-Outlook-2020 [2] Bloomberg, 2021 ETFS Management (Australia) Ltd (AFSL 466778) (“ETFS”), is the responsible entity and issuer of units in the ETFS S&P Biotech ETF (ASX code: CURE) ARSN: 628 037 105 and ETFS Battery Tech & Lithium ETF (ACDC) ARSN: 605 617 490. The PDS contains all of the details of the offer of units in each of the Funds. Any investment decision should only be considered after reading the relevant offer document in full. This document is communicated by ETFS Management (AUS) Limited (Australian Financial Services Licence Number 466778) (“ETFS”). This document may not be reproduced, distributed or published by any recipient for any purpose. Under no circumstances is this document to be used or considered as an offer to sell, or a solicitation of an offer to buy, any securities, investments or other financial instruments and any investments should only be made on the basis of the relevant product disclosure statement which should be considered by any potential investor including any risks identified therein. This document does not take into account your personal needs and financial circumstances. You should seek independent financial, legal, tax and other relevant advice having regard to your particular circumstances. Although we use reasonable efforts to obtain reliable, comprehensive information, we make no representation and give no warranty that it is accurate or complete. Investments in any product issued by ETFS are subject to investment risk, including possible delays in repayment and loss of income and principal invested. Neither ETFS, ETFS Capital Limited nor any other member of the ETFS Capital Group guarantees the performance of any products issued by ETFS or the repayment of capital or any particular rate of return therefrom. The value or return of an investment will fluctuate and investors may lose some or all of their investment. Past performance is not an indication of future performance. ETFS Battery Tech & Lithium ETF: The financial instrument is not sponsored, promoted, sold or supported in any other manner by Solactive AG nor does Solactive AG offer any express or implicit guarantee or assurance either with regard to the results of using the Index and/or Index trade mark or the Index Price at any time or in any other respect. The Index is calculated and published by Solactive AG. Solactive AG uses its best efforts to ensure that the Index is calculated correctly. Irrespective of its obligations towards the Issuer, Solactive AG has no obligation to point out errors in the Index to third parties including but not limited to investors and/or financial intermediaries of the financial instrument. Neither publication of the Index by Solactive AG nor the licensing of the Index or Index trade mark for the purpose of use in connection with the financial instrument constitutes a recommendation by Solactive AG to invest capital in said financial instrument nor does it in any way represent an assurance or opinion of Solactive AG with regard to any investment in this financial instrument. Solactive AG will not be responsible for the consequences of reliance upon any opinion or statement contained herein or for any omission. ETFS S&P Biotech ETF: Standard & Poor's S&P Indices are trademarks of Standard & Poor's Financial Services LLC. “S&P”, as used in the term S&P 500, is a trademark of Standard & Poor's Financial Services LLC ("S&P") respectively, and has been licensed for use by ETFS. ETFS products are not sponsored, endorsed, sold or promoted by S&P, and S&P does not make any representation regarding the advisability of investing in ETFS products.
